THORNE HEALTHTECH INC (THRN) Stock Fundamental Analysis
USA - NASDAQ:THRN - US8852601090 - Common Stock
10.19 USD
-0.01 (-0.1%)
10.17 USD
-0.02 (-0.2%)
Overall THRN gets a fundamental rating of 4 out of 10. We evaluated THRN against 34 industry peers in the Personal Care Products industry. Both the profitability and the financial health of THRN get a neutral evaluation. Nothing too spectacular is happening here. THRN is valued quite expensive, but it does show an excellent growth.
1. Profitability
1.1 Basic Checks
THRN had positive earnings in the past year.
THRN had a positive operating cash flow in the past year.
1.2 Ratios
The Return On Assets of THRN (7.20%) is better than 75.00% of its industry peers.
The Return On Equity of THRN (13.21%) is better than 75.00% of its industry peers.
THRN's Return On Invested Capital of 4.69% is in line compared to the rest of the industry. THRN outperforms 55.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for THRN is significantly below the industry average of 12.80%.
The last Return On Invested Capital (4.69%) for THRN is above the 3 year average (2.99%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.2% | ||
| ROE | 13.21% | ||
| ROIC | 4.69% |
ROA(3y)2.02%
ROA(5y)N/A
ROE(3y)2.55%
ROE(5y)N/A
ROIC(3y)2.99%
ROIC(5y)N/A
1.3 Margins
The Profit Margin of THRN (7.94%) is better than 70.00% of its industry peers.
Looking at the Operating Margin, with a value of 5.26%, THRN is in line with its industry, outperforming 55.00% of the companies in the same industry.
Looking at the Gross Margin, with a value of 50.15%, THRN is in line with its industry, outperforming 47.50% of the companies in the same industry.
In the last couple of years the Gross Margin of THRN has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.26% | ||
| PM (TTM) | 7.94% | ||
| GM | 50.15% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.81%
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so THRN is destroying value.
The number of shares outstanding for THRN has been increased compared to 1 year ago.
Compared to 1 year ago, THRN has a worse debt to assets ratio.
2.2 Solvency
THRN has an Altman-Z score of 3.41. This indicates that THRN is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of THRN (3.41) is better than 67.50% of its industry peers.
THRN has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
THRN has a Debt to Equity ratio of 0.17. This is comparable to the rest of the industry: THRN outperforms 57.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.17 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 3.41 |
ROIC/WACC0.5
WACC9.44%
2.3 Liquidity
A Current Ratio of 2.41 indicates that THRN has no problem at all paying its short term obligations.
The Current ratio of THRN (2.41) is better than 70.00% of its industry peers.
THRN has a Quick Ratio of 1.13. This is a normal value and indicates that THRN is financially healthy and should not expect problems in meeting its short term obligations.
THRN has a Quick ratio of 1.13. This is comparable to the rest of the industry: THRN outperforms 50.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.41 | ||
| Quick Ratio | 1.13 |
3. Growth
3.1 Past
THRN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 660.00%, which is quite impressive.
The Revenue has grown by 23.25% in the past year. This is a very strong growth!
The Revenue has been growing by 30.66% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)660%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%172.73%
Revenue 1Y (TTM)23.25%
Revenue growth 3Y30.66%
Revenue growth 5YN/A
Sales Q2Q%29.69%
3.2 Future
The Earnings Per Share is expected to grow by 55.06% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 21.84% on average over the next years. This is a very strong growth
EPS Next Y14.31%
EPS Next 2Y46.48%
EPS Next 3Y55.06%
EPS Next 5YN/A
Revenue Next Year23.62%
Revenue Next 2Y24.38%
Revenue Next 3Y21.84%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 26.82 indicates a quite expensive valuation of THRN.
65.00% of the companies in the same industry are more expensive than THRN, based on the Price/Earnings ratio.
THRN's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 25.67.
Based on the Price/Forward Earnings ratio of 16.38, the valuation of THRN can be described as correct.
77.50% of the companies in the same industry are more expensive than THRN, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 31.86, THRN is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.82 | ||
| Fwd PE | 16.38 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of THRN is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 28.54 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as THRN's earnings are expected to grow with 55.06% in the coming years.
PEG (NY)1.87
PEG (5Y)N/A
EPS Next 2Y46.48%
EPS Next 3Y55.06%
5. Dividend
5.1 Amount
No dividends for THRN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
10.19
-0.01 (-0.1%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners0.03%
Inst Owner Change0%
Ins Owners10.68%
Ins Owner Change0%
Market Cap550.67M
Revenue(TTM)255.95M
Net Income(TTM)20.33M
Analysts80
Price Target8.61 (-15.51%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-40.77%
Min EPS beat(2)-112.25%
Max EPS beat(2)30.72%
EPS beat(4)2
Avg EPS beat(4)-25.45%
Min EPS beat(4)-112.25%
Max EPS beat(4)30.72%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.37%
Min Revenue beat(2)-3.4%
Max Revenue beat(2)4.13%
Revenue beat(4)1
Avg Revenue beat(4)-4.4%
Min Revenue beat(4)-9.72%
Max Revenue beat(4)4.13%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.28%
PT rev (3m)20.57%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)5.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.7%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.81%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.82 | ||
| Fwd PE | 16.38 | ||
| P/S | 2.15 | ||
| P/FCF | N/A | ||
| P/OCF | 25.59 | ||
| P/B | 3.58 | ||
| P/tB | 4.63 | ||
| EV/EBITDA | 28.54 |
EPS(TTM)0.38
EY3.73%
EPS(NY)0.62
Fwd EY6.11%
FCF(TTM)-0.28
FCFYN/A
OCF(TTM)0.4
OCFY3.91%
SpS4.74
BVpS2.85
TBVpS2.2
PEG (NY)1.87
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.2% | ||
| ROE | 13.21% | ||
| ROCE | 5.95% | ||
| ROIC | 4.69% | ||
| ROICexc | 5.07% | ||
| ROICexgc | 6.08% | ||
| OM | 5.26% | ||
| PM (TTM) | 7.94% | ||
| GM | 50.15% | ||
| FCFM | N/A |
ROA(3y)2.02%
ROA(5y)N/A
ROE(3y)2.55%
ROE(5y)N/A
ROIC(3y)2.99%
ROIC(5y)N/A
ROICexc(3y)4.22%
ROICexc(5y)N/A
ROICexgc(3y)5.36%
ROICexgc(5y)N/A
ROCE(3y)3.82%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.81%
GM growth 5YN/A
F-Score5
Asset Turnover0.91
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.17 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 1.31 | ||
| Cap/Depr | 590.87% | ||
| Cap/Sales | 14.33% | ||
| Interest Coverage | 19.78 | ||
| Cash Conversion | 109.39% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.41 | ||
| Quick Ratio | 1.13 | ||
| Altman-Z | 3.41 |
F-Score5
WACC9.44%
ROIC/WACC0.5
Cap/Depr(3y)158.15%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.08%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)660%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%172.73%
EPS Next Y14.31%
EPS Next 2Y46.48%
EPS Next 3Y55.06%
EPS Next 5YN/A
Revenue 1Y (TTM)23.25%
Revenue growth 3Y30.66%
Revenue growth 5YN/A
Sales Q2Q%29.69%
Revenue Next Year23.62%
Revenue Next 2Y24.38%
Revenue Next 3Y21.84%
Revenue Next 5YN/A
EBIT growth 1Y1143.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year248.89%
EBIT Next 3Y103.9%
EBIT Next 5YN/A
FCF growth 1Y-266.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y78.29%
OCF growth 3YN/A
OCF growth 5YN/A
THORNE HEALTHTECH INC / THRN FAQ
What is the ChartMill fundamental rating of THORNE HEALTHTECH INC (THRN) stock?
ChartMill assigns a fundamental rating of 4 / 10 to THRN.
What is the valuation status of THORNE HEALTHTECH INC (THRN) stock?
ChartMill assigns a valuation rating of 3 / 10 to THORNE HEALTHTECH INC (THRN). This can be considered as Overvalued.
Can you provide the profitability details for THORNE HEALTHTECH INC?
THORNE HEALTHTECH INC (THRN) has a profitability rating of 4 / 10.
How financially healthy is THORNE HEALTHTECH INC?
The financial health rating of THORNE HEALTHTECH INC (THRN) is 4 / 10.
Can you provide the dividend sustainability for THRN stock?
The dividend rating of THORNE HEALTHTECH INC (THRN) is 0 / 10 and the dividend payout ratio is 0%.